Causaly
The company provides an agentic AI platform designed for life sciences R&D to accelerate drug discovery and clinical development. Its technology combines a high-precision biomedical knowledge graph with generative AI copilots to automate scientific workflows, such as target identification, biomarker discovery, and lead prioritization. The platform serves large pharmaceutical enterprises by integrating internal proprietary data with external scientific evidence to inform pipeline decisions.
Life Sciences
Biotechnology
Artificial Intelligence
Pharmaceuticals
Funding summary
- Total raised
- €72.5M
- Funding rounds
- 4
Investors in Causaly
Investors on record for Causaly. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Causaly?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors